HUP0101215A2 - Kristályos formájú paroxetin - Google Patents
Kristályos formájú paroxetinInfo
- Publication number
- HUP0101215A2 HUP0101215A2 HU0101215A HUP0101215A HUP0101215A2 HU P0101215 A2 HUP0101215 A2 HU P0101215A2 HU 0101215 A HU0101215 A HU 0101215A HU P0101215 A HUP0101215 A HU P0101215A HU P0101215 A2 HUP0101215 A2 HU P0101215A2
- Authority
- HU
- Hungary
- Prior art keywords
- paroxetine
- product according
- depression
- treatment
- infrared spectrum
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 3
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 3
- 229960002296 paroxetine Drugs 0.000 title abstract 3
- 208000020401 Depressive disease Diseases 0.000 abstract 2
- 238000002329 infrared spectrum Methods 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A tal lm ny krist lyos form ban lévő paroxetin szabad b zisravonatkozik. A krist lyos paroxetin szabad b zist egy az infrav"r"sspektrumban (nujol mull) k"rülbelül 3330 cm-1-nél lévő éles s vjellemzi, amely s v a folyékony forma infrav"r"s spektrum ban nincsjelen. A tal lm ny tov bbi t rgyait képezik a k"vetkezők: -gyógyszerkészítmény, amely egy tal lm ny szerinti terméket és gyógyszatilag elfogadható hordozót tartalmaz; - egy tal lm ny szerintitermék alkalmaz sa depresszió kezelésére szolg lógyógyszerkészítmények elő llít s ra; és - elj r s depressziókezelésére, amelynek sor n egy egy vagy t"bb rendellenességbenszenvedő betegnek egy tal lm ny szerinti termék hat sos vagyprofilaktikus mennyiségét adj k be. Ó
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805581.7A GB9805581D0 (en) | 1998-03-16 | 1998-03-16 | Novel compounds |
| GBGB9813054.5A GB9813054D0 (en) | 1998-06-17 | 1998-06-17 | Novel compounds |
| GBGB9817115.0A GB9817115D0 (en) | 1998-08-06 | 1998-08-06 | Novel compounds |
| PCT/GB1999/000793 WO1999047519A1 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0101215A2 true HUP0101215A2 (hu) | 2002-04-29 |
| HUP0101215A3 HUP0101215A3 (en) | 2002-05-28 |
Family
ID=27269245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101215A HUP0101215A3 (en) | 1998-03-16 | 1999-03-16 | Chrystalline form of paroxetine |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1064282A1 (hu) |
| JP (1) | JP2002506865A (hu) |
| KR (1) | KR20010041947A (hu) |
| CN (1) | CN1300286A (hu) |
| AP (1) | AP2000001907A0 (hu) |
| AU (1) | AU2847199A (hu) |
| BG (1) | BG104839A (hu) |
| BR (1) | BR9908825A (hu) |
| CA (1) | CA2323896A1 (hu) |
| EA (1) | EA200000946A1 (hu) |
| HU (1) | HUP0101215A3 (hu) |
| ID (1) | ID27596A (hu) |
| IL (1) | IL138390A0 (hu) |
| NO (1) | NO20004583L (hu) |
| PL (1) | PL342931A1 (hu) |
| SK (1) | SK13622000A3 (hu) |
| TR (1) | TR200002675T2 (hu) |
| WO (1) | WO1999047519A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| GB9919052D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel compound composition and process |
| US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| AR001982A1 (es) * | 1995-02-06 | 1998-01-07 | Smithkline Beecham Plc | Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion |
-
1999
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Application Discontinuation
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Application Discontinuation
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
-
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9908825A (pt) | 2000-11-21 |
| WO1999047519A1 (en) | 1999-09-23 |
| KR20010041947A (ko) | 2001-05-25 |
| PL342931A1 (en) | 2001-07-16 |
| EA200000946A1 (ru) | 2001-02-26 |
| CN1300286A (zh) | 2001-06-20 |
| ID27596A (id) | 2001-04-12 |
| NO20004583D0 (no) | 2000-09-14 |
| NO20004583L (no) | 2000-09-15 |
| EP1064282A1 (en) | 2001-01-03 |
| HUP0101215A3 (en) | 2002-05-28 |
| TR200002675T2 (tr) | 2000-12-21 |
| SK13622000A3 (sk) | 2001-03-12 |
| IL138390A0 (en) | 2001-10-31 |
| BG104839A (en) | 2001-09-28 |
| JP2002506865A (ja) | 2002-03-05 |
| CA2323896A1 (en) | 1999-09-23 |
| AP2000001907A0 (en) | 2000-09-30 |
| AU2847199A (en) | 1999-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| HUP0104702A2 (hu) | Klosztridium toxinszármazékok alkalmazása horkolási zajok elnyomására szolgáló gyógyászati készítmények előállítására | |
| HUP0400529A2 (hu) | Klórpromazin és pentamidin alkalmazása daganatképződéssel járó rendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására | |
| CA2031714A1 (en) | R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them | |
| FR2558373B1 (fr) | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee | |
| PH31394A (en) | Certain Ä,2,5-thiadiazol-4-ylÜ-1-azabicyclo Ä3,2,1Üoctane derivaives and their pharmaceutical uses. | |
| HUP9902105A2 (hu) | Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása | |
| BG104727A (en) | Pharmaceutical composition of topiramate | |
| HUP0100949A2 (hu) | Aril kondenzált azapoliciklusos vegyületek és ezeket tartalmazó gyógyászati készítmények | |
| CA2153340A1 (fr) | Application du riluzole dans le traitement de la maladie de parkinson et des syndromes parkinsoniens | |
| HUP0300030A2 (en) | Bupropion metabolites and methods of their synthesis and use and pharmaceutical compositions containing them and and their use | |
| MX9706647A (es) | Composiciones farmaceuticas que comprenden inhibidores de oxidasa b de monoamina. | |
| HUP0102728A2 (hu) | Módszerek és transzdermális készítmények fájdalom csillapítására | |
| KR960700716A (ko) | Aids-관련 신경 장애를 치료하기 위한 리루졸의 사용(use of riluzole for treating aids-related neural disorders) | |
| HUP0001014A2 (hu) | Gasztrointesztinális lipáz inhibitorok felhasználása | |
| ATE219670T1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
| DE60002126D1 (de) | Substituierte dimere Carboxamid-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
| NZ320355A (en) | Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6- tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| ATE235901T1 (de) | Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen | |
| MX9603606A (es) | N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida. | |
| HK1079688A1 (en) | Statin product for enhancing cognitive maintenance | |
| HUP0101215A2 (hu) | Kristályos formájú paroxetin | |
| HUP0204391A2 (en) | The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders | |
| HUP0003803A2 (hu) | Flunarizin alkalmazása zöldhályog helyi kezelésére alkalmas gyógyszerkészítmény előállítására |